Webinar: COVID-19 Updates with Stephanie Lambert
•
0 likes•148 views
Stephanie Lambert, Health Officer, Manitowoc County Health Department shares some COVID-19 updates for October 2021, view the recording here: https://www.facebook.com/TheChamberofManitowocCounty/videos/377583460764338
Report
Share
Report
Share
Download to read offline
Recommended
Novel coronavirus (COVID-19) etiological characteristics, clinical manifestat...
1. The document discusses the etiological characteristics, clinical manifestations, and management of the novel coronavirus (COVID-19). It describes how the virus spreads through respiratory droplets and contact, and its symptoms which range from asymptomatic to severe.
2. Diagnosis involves PCR testing of respiratory samples, chest imaging showing pneumonia, and elevated inflammatory markers in severe cases. Treatment involves isolation, supportive care, and management of complications.
3. Prevention strategies include hand washing, physical distancing, and disinfecting surfaces. The document also proposes some Unani formulations that may provide adjuvant therapy for COVID-19.
Novel coronavirus-19
- A novel coronavirus was identified in Wuhan, China in late 2019 and caused a pneumonia outbreak. It has since spread globally resulting in the COVID-19 pandemic.
- SARS-CoV-2, the virus that causes COVID-19, is transmitted primarily through respiratory droplets. It has an incubation period of up to 14 days. Clinical features range from mild to severe/critical illness.
- Diagnosis is made through RT-PCR testing of respiratory samples. Chest CT may show signs of viral pneumonia. Management involves isolation and supportive care, with investigational antiviral treatments being explored.
Management of covid 19
MANAGEMENT OF COVID-19 AT COMMUNITY LEVEL, NON-ICU SETTINGS, CRITICAL CARE MANAGEMENT AND NEONATAL COVID.
Healthy sure covid care hand guide
This document provides guidance on COVID-19 care and testing in Mumbai, India. It outlines what to do if experiencing COVID-19 symptoms, such as consulting a family doctor to prescribe a COVID test or determine if home or institutional quarantine is needed. It describes how and where to get tested, the different levels of care (home, institutional quarantine, hospitalization), estimated costs of treatment depending on hospital size and public versus private, and precautions like maintaining sanitation and monitoring oxygen levels.
Covid 19 management update - Sohag Heart Center Experience
This document provides guidance on the management of COVID-19 patients based on the experience of Sohag Heart Center in Egypt. It discusses evaluation, general management, specific therapies, and care of critically ill and non-hospitalized patients. For non-hospitalized patients, it recommends symptomatic treatment and hospitalization for those at higher risk. For hospitalized patients, it suggests supportive care including oxygen supplementation, anticoagulation for prevention of thromboembolism, and judicious use of antibiotics. It recommends against medications like hydroxychloroquine, ivermectin, and favipiravir outside of clinical trials due to lack of proven benefit. For critically ill patients, it supports treatments like dexamethasone,
Covid 19 infection and management
This document provides information on COVID-19 infection, including its symptoms, diagnostic tests, and treatment approaches. It describes the stages of infection from uncomplicated illness to septic shock. Treatment recommendations include vitamin and mineral supplements, antiviral and anti-inflammatory drugs, oxygen support, anticoagulation, intensive care as needed. For critical cases, salvage therapies like plasma exchange and ECMO are mentioned. Close monitoring of markers and managing post-ICU care is also outlined.
Corona
The document discusses COVID-19, including what it is, its symptoms, testing procedures, treatment options, and preventive measures. It explains that COVID-19 is caused by the SARS-CoV-2 virus, that symptoms can range from mild to severe and include fever, cough and shortness of breath, and that molecular tests like PCR are used to detect the virus. It recommends measures like masks, distancing and handwashing to prevent transmission.
Covid-19
This document provides guidance on the initial management and treatment of COVID-19. It discusses triaging patients with suspected COVID-19 and implementing appropriate infection prevention and control measures. It recommends hospitalizing high-risk patients or those with severe acute respiratory infection (SARI) complications. Treatment options discussed include oxygen therapy, antimicrobial therapy, and care of SARI patients in emergency and ICU settings. Specimen collection and safe patient transfer are also covered.
Recommended
Novel coronavirus (COVID-19) etiological characteristics, clinical manifestat...
1. The document discusses the etiological characteristics, clinical manifestations, and management of the novel coronavirus (COVID-19). It describes how the virus spreads through respiratory droplets and contact, and its symptoms which range from asymptomatic to severe.
2. Diagnosis involves PCR testing of respiratory samples, chest imaging showing pneumonia, and elevated inflammatory markers in severe cases. Treatment involves isolation, supportive care, and management of complications.
3. Prevention strategies include hand washing, physical distancing, and disinfecting surfaces. The document also proposes some Unani formulations that may provide adjuvant therapy for COVID-19.
Novel coronavirus-19
- A novel coronavirus was identified in Wuhan, China in late 2019 and caused a pneumonia outbreak. It has since spread globally resulting in the COVID-19 pandemic.
- SARS-CoV-2, the virus that causes COVID-19, is transmitted primarily through respiratory droplets. It has an incubation period of up to 14 days. Clinical features range from mild to severe/critical illness.
- Diagnosis is made through RT-PCR testing of respiratory samples. Chest CT may show signs of viral pneumonia. Management involves isolation and supportive care, with investigational antiviral treatments being explored.
Management of covid 19
MANAGEMENT OF COVID-19 AT COMMUNITY LEVEL, NON-ICU SETTINGS, CRITICAL CARE MANAGEMENT AND NEONATAL COVID.
Healthy sure covid care hand guide
This document provides guidance on COVID-19 care and testing in Mumbai, India. It outlines what to do if experiencing COVID-19 symptoms, such as consulting a family doctor to prescribe a COVID test or determine if home or institutional quarantine is needed. It describes how and where to get tested, the different levels of care (home, institutional quarantine, hospitalization), estimated costs of treatment depending on hospital size and public versus private, and precautions like maintaining sanitation and monitoring oxygen levels.
Covid 19 management update - Sohag Heart Center Experience
This document provides guidance on the management of COVID-19 patients based on the experience of Sohag Heart Center in Egypt. It discusses evaluation, general management, specific therapies, and care of critically ill and non-hospitalized patients. For non-hospitalized patients, it recommends symptomatic treatment and hospitalization for those at higher risk. For hospitalized patients, it suggests supportive care including oxygen supplementation, anticoagulation for prevention of thromboembolism, and judicious use of antibiotics. It recommends against medications like hydroxychloroquine, ivermectin, and favipiravir outside of clinical trials due to lack of proven benefit. For critically ill patients, it supports treatments like dexamethasone,
Covid 19 infection and management
This document provides information on COVID-19 infection, including its symptoms, diagnostic tests, and treatment approaches. It describes the stages of infection from uncomplicated illness to septic shock. Treatment recommendations include vitamin and mineral supplements, antiviral and anti-inflammatory drugs, oxygen support, anticoagulation, intensive care as needed. For critical cases, salvage therapies like plasma exchange and ECMO are mentioned. Close monitoring of markers and managing post-ICU care is also outlined.
Corona
The document discusses COVID-19, including what it is, its symptoms, testing procedures, treatment options, and preventive measures. It explains that COVID-19 is caused by the SARS-CoV-2 virus, that symptoms can range from mild to severe and include fever, cough and shortness of breath, and that molecular tests like PCR are used to detect the virus. It recommends measures like masks, distancing and handwashing to prevent transmission.
Covid-19
This document provides guidance on the initial management and treatment of COVID-19. It discusses triaging patients with suspected COVID-19 and implementing appropriate infection prevention and control measures. It recommends hospitalizing high-risk patients or those with severe acute respiratory infection (SARI) complications. Treatment options discussed include oxygen therapy, antimicrobial therapy, and care of SARI patients in emergency and ICU settings. Specimen collection and safe patient transfer are also covered.
Aiims covid protocol
This document provides protocols for COVID-19 management at AIIMS. It discusses criteria for suspecting COVID-19 cases, guidelines for asymptomatic and symptomatic healthcare workers exposed to COVID-19, and protocols for managing mild, moderate and severe COVID-19 cases. It also outlines protocols for prone ventilation, transferring intubated patients, discharge criteria, and home isolation eligibility. The document provides detailed instructions for patients and their family members on self-isolation and environmental sanitation.
Covid 19 management 6 months later
coronavirus
COVID-19
SARS-CoV2
Management
treatment
investigations
ivermectin
remdesivir
radiology
Lopinavir
convalescent plasma
hydroxychloroquine
antiinflammatory
anticoagulant
NSAIDs
colchicine
tocilizumab
laboratory
diagnosis
antiviral
herbal
Management of Mild to Moderate COVID cases -VSGH Protocol
The document discusses clinical staging and management of COVID-19 patients. It proposes a 4 stage clinical staging system: Stage I (asymptomatic to mild symptoms), Stage IIA (moderate pulmonary involvement without hypoxia), Stage IIB (moderate pulmonary involvement with hypoxia), Stage III (severe systemic hyperinflammation). Treatment protocols are outlined for each stage, including recommended investigations, medications, and criteria for transfer to higher levels of care. Comorbid conditions are also factored into the clinical staging and management guidelines.
Pzaa114
This document provides recommendations for physical therapists managing hospitalized patients with COVID-19 in the Netherlands. It recommends minimizing direct contact with COVID-19 patients and using personal protective equipment if needed. Treatment involves respiratory support and active mobilization, tailored to the patient's severity and needs. Recommendations cover safety protocols, treatments for critically ill ICU patients and severely ill ward patients, discharge planning, and staffing considerations. The guidance aims to support patient recovery and therapist safety during the pandemic.
PERIOPERATIVE MANAGEMENT OF COVID 19 SUSPECT/ CONFIRMED PATIENT
These recommendations are based on recent guidelines and protocols followed in major hospitals in India and also from recent articles published online. This cannot be taken as final. Guidelines will be updated from time to time.
Watch this presentation in laptop/ pc as slideshow for beautiful animations.
Corona Virus
Describes all about SARS CoV- 2 its introduction, epidemiology, life cycle of virus, its transmission, pathophysiology of the disease, its complications, diagnostic methods and management through different system of medicines.
Covid 19 advancement in treatment over time
This document discusses various aspects of diagnosing and treating COVID-19, including:
1. The timing of initiating antiviral, anti-inflammatory, and anticoagulant treatments is important, with antivirals recommended early in symptomatic phase and steroids in pulmonary phase.
2. Remdesivir has been shown to shorten recovery time in moderately ill hospitalized patients. Tocilizumab was not effective at preventing intubation or death.
3. Treatment protocols for mild, moderate, and severe COVID-19 cases are outlined, recommending medications, supplements, and monitoring based on disease severity and stage.
Weitzman ECHO COVID-19 “Long Haulers”
This document discusses "long haulers" or patients experiencing persistent symptoms after acute COVID-19 infection. It provides epidemiological data showing a significant portion of patients reporting ongoing symptoms weeks or months after initial infection. Two case presentations are provided - one with a 73F experiencing dyspnea, fatigue and loss of taste months after hospitalization and found to have diastolic dysfunction. The second case is a 51F with intermittent cough and dyspnea for months with abnormal CT findings suggestive of organizing pneumonia. Management strategies are discussed for post-COVID headaches.
COVID-19 by Dr Bodhisatwa Choudhuri
COVID-19 (Coronavirus Disease 2019) is an infectious disease caused by the recently found virus known as SARS-CoV-2 (or coronavirus). Before the outbreak originated in Wuhan, China on December 2019, there was no information about this virus. Case Definition (India), Symptoms, Statistics, Preventive Measures, Management
Typical & atypical clinical presentations of COVID-19 in children
A brief presentation about some typical symptoms in children diagnosed with COVID-19 in Oman along with atypical or unusual presentations of the disease in the same age group in the USA and Bahrain.
PERINATAL AND NEONATAL MANAGEMENT OF COVID 19 INFECTION by DR.AKHILA
This document provides recommendations from FOGSI, NNF, and IAP on the perinatal-neonatal management of COVID-19 infection. It addresses 20 questions on topics like care of pregnant women with COVID-19, testing guidelines, delivery location, infection control during delivery, neonatal resuscitation precautions, neonatal care protocols, testing and treatment of infected newborns, breastfeeding recommendations, visitation policies, and occupational health policies. The recommendations emphasize isolation, use of personal protective equipment, limiting exposure risk during delivery and neonatal resuscitation, rooming-in of healthy mother-newborn pairs when possible, and following national treatment guidelines that do not currently recommend specific antiviral drugs.
Covid 19 (1)
The document summarizes information and recommendations regarding the Covid-19 pandemic from the perspective of intensive care and critical care specialists. It provides worldwide case statistics and outlines anticipated critical care bed needs for a hospital. It also discusses ventilation strategies, the use of ECMO, guidelines from medical societies, PPE recommendations, management of shock, antibiotics, experimental drug treatments and ongoing clinical trials. The overall focus is on evaluating and treating critically ill Covid-19 patients from an intensive care perspective.
Advance Management of COVID-19: RECOVERY Trial
The document summarizes the Recovery Trial, which is a large-scale randomized controlled trial in the UK investigating potential treatments for COVID-19. It is testing several proposed interventions, including hydroxychloroquine, lopinavir-ritonavir, dexamethasone, and convalescent plasma. Initial results found no benefit from hydroxychloroquine or lopinavir-ritonavir. Dexamethasone was found to reduce mortality in patients requiring oxygen or ventilation. The document also outlines protocols for managing COVID-19 cases based on severity, including investigations, treatment approaches, and discharge criteria.
Med j club mm covid20
- Coronaviruses typically cause common colds but SARS-CoV and MERS-CoV can cause pneumonia, respiratory failure, and death. A novel coronavirus, SARS-CoV-2, emerged in Wuhan, China in late 2019 and caused a global pandemic.
- SARS-CoV-2 spreads mainly through respiratory droplets when people cough, sneeze or talk within 6 feet of each other. Asymptomatic and pre-symptomatic people are highly infectious.
- COVID-19 symptoms range from mild to critical illness. The elderly and those with pre-existing conditions are at higher risk for severe disease. Diagnosis involves PCR testing of respiratory samples.
Covid 19 and CHD
COVID-19 is caused by SARS-CoV-2 virus and has developed into a worldwide pandemic. The virus can affect the cardiovascular system by directly infecting heart cells or causing inflammation. For those with congenital heart disease, risk of serious illness from COVID-19 is higher for those over 70, with complex heart conditions, lung disease, or other health problems. While little is known about effects on those with CHD, children may be less severely affected than adults. Treatment focuses on symptoms, and most cases can be managed at home with self-care.
Multisystem Inflammatory Syndrome in Children
Multisystem Inflammatory Syndrome in Children (MIS-C) is a new condition linked to COVID-19 where different body parts can become inflamed. It has been reported worldwide since April 2020. The main symptoms include persistent fever plus inflammation in at least two organs, such as the gastrointestinal, skin, or vascular systems. The cause is believed to be an abnormal immune response to the COVID-19 virus several weeks after infection. While most children recover, some have developed severe illness requiring intensive care including heart problems. Treatment focuses on stabilization, medications to reduce inflammation, and monitoring for complications.
COVID 19 Updates
1) The document provides definitions for suspected, probable, and confirmed cases of COVID-19 according to WHO criteria based on symptoms, exposure history, and test results.
2) It describes the typical progression and severity of COVID-19 from mild to severe and critical illness, with severe cases making up 14% of cases and critical 5%. The overall fatality rate is estimated between 2.3-5%.
3) Risk factors for worse outcomes include older age, male sex, comorbidities like cardiovascular disease, and certain lab abnormalities like lymphopenia and elevated LDH, troponin, and D-Dimer levels.
Covid 19 diagnosis and treatment
This was a lecture I gave for the Upstate Nurse Practitioners Association. This is a comprehensive overview. I would to thank all health care professionals for doing their jobs as well as they can.
Management of covid 19 infected patients
1) Diabetes is a major risk factor for severe illness from COVID-19, with studies showing people with diabetes are at higher risk of mortality.
2) Guidelines recommend people with diabetes who get COVID-19 closely monitor their blood glucose and follow sick day rules for diabetes. They may need adjusted diabetes medication dosages.
3) Some evidence suggests chloroquine or hydroxychloroquine may help treat COVID-19, but more research is still needed. Ibuprofen use is not recommended due to theoretical risks, and acetaminophen is preferred instead.
Covid 19
In COVID-19 any antiviral is more effective when used early in first week of illness.
What should not be used in covid-19 is also discussed in presentation.
Management of Covid Positive Pregnancy
The document discusses COVID-19 in pregnancy and provides guidance for antenatal care during the pandemic. It notes that pregnant women are not more susceptible to COVID-19 infection but may be at higher risk of severe disease. It recommends reducing and spacing antenatal appointments, conducting scans based on clinical need, and monitoring home vitals. Guidance is provided for care during labor and postpartum while minimizing viral transmission. Vaccination during pregnancy is not currently recommended but is safe during lactation.
Infertility
L.A., a 29-year-old female, presented with a 7-year history of infertility despite frequent unprotected intercourse following her last successful delivery 7 years ago. Physical examination and tests revealed partial uterine synechiae (Asherman's syndrome). She underwent dilatation and curettage with insertion of an IUCD. Her partner's semen analysis was pending due to a delayed COVID-19 test result. Infertility workup and treatments were discussed.
More Related Content
What's hot
Aiims covid protocol
This document provides protocols for COVID-19 management at AIIMS. It discusses criteria for suspecting COVID-19 cases, guidelines for asymptomatic and symptomatic healthcare workers exposed to COVID-19, and protocols for managing mild, moderate and severe COVID-19 cases. It also outlines protocols for prone ventilation, transferring intubated patients, discharge criteria, and home isolation eligibility. The document provides detailed instructions for patients and their family members on self-isolation and environmental sanitation.
Covid 19 management 6 months later
coronavirus
COVID-19
SARS-CoV2
Management
treatment
investigations
ivermectin
remdesivir
radiology
Lopinavir
convalescent plasma
hydroxychloroquine
antiinflammatory
anticoagulant
NSAIDs
colchicine
tocilizumab
laboratory
diagnosis
antiviral
herbal
Management of Mild to Moderate COVID cases -VSGH Protocol
The document discusses clinical staging and management of COVID-19 patients. It proposes a 4 stage clinical staging system: Stage I (asymptomatic to mild symptoms), Stage IIA (moderate pulmonary involvement without hypoxia), Stage IIB (moderate pulmonary involvement with hypoxia), Stage III (severe systemic hyperinflammation). Treatment protocols are outlined for each stage, including recommended investigations, medications, and criteria for transfer to higher levels of care. Comorbid conditions are also factored into the clinical staging and management guidelines.
Pzaa114
This document provides recommendations for physical therapists managing hospitalized patients with COVID-19 in the Netherlands. It recommends minimizing direct contact with COVID-19 patients and using personal protective equipment if needed. Treatment involves respiratory support and active mobilization, tailored to the patient's severity and needs. Recommendations cover safety protocols, treatments for critically ill ICU patients and severely ill ward patients, discharge planning, and staffing considerations. The guidance aims to support patient recovery and therapist safety during the pandemic.
PERIOPERATIVE MANAGEMENT OF COVID 19 SUSPECT/ CONFIRMED PATIENT
These recommendations are based on recent guidelines and protocols followed in major hospitals in India and also from recent articles published online. This cannot be taken as final. Guidelines will be updated from time to time.
Watch this presentation in laptop/ pc as slideshow for beautiful animations.
Corona Virus
Describes all about SARS CoV- 2 its introduction, epidemiology, life cycle of virus, its transmission, pathophysiology of the disease, its complications, diagnostic methods and management through different system of medicines.
Covid 19 advancement in treatment over time
This document discusses various aspects of diagnosing and treating COVID-19, including:
1. The timing of initiating antiviral, anti-inflammatory, and anticoagulant treatments is important, with antivirals recommended early in symptomatic phase and steroids in pulmonary phase.
2. Remdesivir has been shown to shorten recovery time in moderately ill hospitalized patients. Tocilizumab was not effective at preventing intubation or death.
3. Treatment protocols for mild, moderate, and severe COVID-19 cases are outlined, recommending medications, supplements, and monitoring based on disease severity and stage.
Weitzman ECHO COVID-19 “Long Haulers”
This document discusses "long haulers" or patients experiencing persistent symptoms after acute COVID-19 infection. It provides epidemiological data showing a significant portion of patients reporting ongoing symptoms weeks or months after initial infection. Two case presentations are provided - one with a 73F experiencing dyspnea, fatigue and loss of taste months after hospitalization and found to have diastolic dysfunction. The second case is a 51F with intermittent cough and dyspnea for months with abnormal CT findings suggestive of organizing pneumonia. Management strategies are discussed for post-COVID headaches.
COVID-19 by Dr Bodhisatwa Choudhuri
COVID-19 (Coronavirus Disease 2019) is an infectious disease caused by the recently found virus known as SARS-CoV-2 (or coronavirus). Before the outbreak originated in Wuhan, China on December 2019, there was no information about this virus. Case Definition (India), Symptoms, Statistics, Preventive Measures, Management
Typical & atypical clinical presentations of COVID-19 in children
A brief presentation about some typical symptoms in children diagnosed with COVID-19 in Oman along with atypical or unusual presentations of the disease in the same age group in the USA and Bahrain.
PERINATAL AND NEONATAL MANAGEMENT OF COVID 19 INFECTION by DR.AKHILA
This document provides recommendations from FOGSI, NNF, and IAP on the perinatal-neonatal management of COVID-19 infection. It addresses 20 questions on topics like care of pregnant women with COVID-19, testing guidelines, delivery location, infection control during delivery, neonatal resuscitation precautions, neonatal care protocols, testing and treatment of infected newborns, breastfeeding recommendations, visitation policies, and occupational health policies. The recommendations emphasize isolation, use of personal protective equipment, limiting exposure risk during delivery and neonatal resuscitation, rooming-in of healthy mother-newborn pairs when possible, and following national treatment guidelines that do not currently recommend specific antiviral drugs.
Covid 19 (1)
The document summarizes information and recommendations regarding the Covid-19 pandemic from the perspective of intensive care and critical care specialists. It provides worldwide case statistics and outlines anticipated critical care bed needs for a hospital. It also discusses ventilation strategies, the use of ECMO, guidelines from medical societies, PPE recommendations, management of shock, antibiotics, experimental drug treatments and ongoing clinical trials. The overall focus is on evaluating and treating critically ill Covid-19 patients from an intensive care perspective.
Advance Management of COVID-19: RECOVERY Trial
The document summarizes the Recovery Trial, which is a large-scale randomized controlled trial in the UK investigating potential treatments for COVID-19. It is testing several proposed interventions, including hydroxychloroquine, lopinavir-ritonavir, dexamethasone, and convalescent plasma. Initial results found no benefit from hydroxychloroquine or lopinavir-ritonavir. Dexamethasone was found to reduce mortality in patients requiring oxygen or ventilation. The document also outlines protocols for managing COVID-19 cases based on severity, including investigations, treatment approaches, and discharge criteria.
Med j club mm covid20
- Coronaviruses typically cause common colds but SARS-CoV and MERS-CoV can cause pneumonia, respiratory failure, and death. A novel coronavirus, SARS-CoV-2, emerged in Wuhan, China in late 2019 and caused a global pandemic.
- SARS-CoV-2 spreads mainly through respiratory droplets when people cough, sneeze or talk within 6 feet of each other. Asymptomatic and pre-symptomatic people are highly infectious.
- COVID-19 symptoms range from mild to critical illness. The elderly and those with pre-existing conditions are at higher risk for severe disease. Diagnosis involves PCR testing of respiratory samples.
Covid 19 and CHD
COVID-19 is caused by SARS-CoV-2 virus and has developed into a worldwide pandemic. The virus can affect the cardiovascular system by directly infecting heart cells or causing inflammation. For those with congenital heart disease, risk of serious illness from COVID-19 is higher for those over 70, with complex heart conditions, lung disease, or other health problems. While little is known about effects on those with CHD, children may be less severely affected than adults. Treatment focuses on symptoms, and most cases can be managed at home with self-care.
Multisystem Inflammatory Syndrome in Children
Multisystem Inflammatory Syndrome in Children (MIS-C) is a new condition linked to COVID-19 where different body parts can become inflamed. It has been reported worldwide since April 2020. The main symptoms include persistent fever plus inflammation in at least two organs, such as the gastrointestinal, skin, or vascular systems. The cause is believed to be an abnormal immune response to the COVID-19 virus several weeks after infection. While most children recover, some have developed severe illness requiring intensive care including heart problems. Treatment focuses on stabilization, medications to reduce inflammation, and monitoring for complications.
COVID 19 Updates
1) The document provides definitions for suspected, probable, and confirmed cases of COVID-19 according to WHO criteria based on symptoms, exposure history, and test results.
2) It describes the typical progression and severity of COVID-19 from mild to severe and critical illness, with severe cases making up 14% of cases and critical 5%. The overall fatality rate is estimated between 2.3-5%.
3) Risk factors for worse outcomes include older age, male sex, comorbidities like cardiovascular disease, and certain lab abnormalities like lymphopenia and elevated LDH, troponin, and D-Dimer levels.
Covid 19 diagnosis and treatment
This was a lecture I gave for the Upstate Nurse Practitioners Association. This is a comprehensive overview. I would to thank all health care professionals for doing their jobs as well as they can.
Management of covid 19 infected patients
1) Diabetes is a major risk factor for severe illness from COVID-19, with studies showing people with diabetes are at higher risk of mortality.
2) Guidelines recommend people with diabetes who get COVID-19 closely monitor their blood glucose and follow sick day rules for diabetes. They may need adjusted diabetes medication dosages.
3) Some evidence suggests chloroquine or hydroxychloroquine may help treat COVID-19, but more research is still needed. Ibuprofen use is not recommended due to theoretical risks, and acetaminophen is preferred instead.
Covid 19
In COVID-19 any antiviral is more effective when used early in first week of illness.
What should not be used in covid-19 is also discussed in presentation.
What's hot (20)
Management of Mild to Moderate COVID cases -VSGH Protocol
Management of Mild to Moderate COVID cases -VSGH Protocol
PERIOPERATIVE MANAGEMENT OF COVID 19 SUSPECT/ CONFIRMED PATIENT
PERIOPERATIVE MANAGEMENT OF COVID 19 SUSPECT/ CONFIRMED PATIENT
Typical & atypical clinical presentations of COVID-19 in children
Typical & atypical clinical presentations of COVID-19 in children
PERINATAL AND NEONATAL MANAGEMENT OF COVID 19 INFECTION by DR.AKHILA
PERINATAL AND NEONATAL MANAGEMENT OF COVID 19 INFECTION by DR.AKHILA
Similar to Webinar: COVID-19 Updates with Stephanie Lambert
Management of Covid Positive Pregnancy
The document discusses COVID-19 in pregnancy and provides guidance for antenatal care during the pandemic. It notes that pregnant women are not more susceptible to COVID-19 infection but may be at higher risk of severe disease. It recommends reducing and spacing antenatal appointments, conducting scans based on clinical need, and monitoring home vitals. Guidance is provided for care during labor and postpartum while minimizing viral transmission. Vaccination during pregnancy is not currently recommended but is safe during lactation.
Infertility
L.A., a 29-year-old female, presented with a 7-year history of infertility despite frequent unprotected intercourse following her last successful delivery 7 years ago. Physical examination and tests revealed partial uterine synechiae (Asherman's syndrome). She underwent dilatation and curettage with insertion of an IUCD. Her partner's semen analysis was pending due to a delayed COVID-19 test result. Infertility workup and treatments were discussed.
Check for general danger signs
This document discusses how to check children for general danger signs such as inability to drink or feed, vomiting everything, convulsions, lethargy or unconsciousness. It outlines how to assess for these signs by asking caregivers questions and examining the child. Common causes of convulsions in children like CNS infections, febrile seizures, and metabolic disorders are reviewed. The approach to evaluating a child presenting with convulsions or coma is described, including taking a history, examining the child and assessing their level of consciousness using the AVPU scale, and conducting basic investigations.
Covid 19 in Pregnancy | Jindal IVF
This document summarizes guidelines for managing a pregnant patient with mild COVID-19 infection. It addresses:
1) Categorizing the patient and managing the case through home isolation with rest, fluids and symptomatic treatment.
2) Providing tips for home isolation including proper ventilation, hygiene, self-monitoring, and instructions for caregivers.
3) Discussing potential impacts of COVID-19 infection on pregnancy including risks of preterm birth and NICU admissions.
4) Answering questions about delivery timing and mode, breastfeeding precautions, COVID-19 vaccination, and post-recovery antenatal surveillance based on stage of pregnancy and clinical status.
How , where , what
This document provides guidance on living with and preventing the spread of coronavirus. It addresses frequently asked questions about COVID-19 symptoms, precautions, sanitization, masks, quarantining, and more. Key recommendations include maintaining social distancing, frequent hand washing, disinfecting surfaces, wearing a mask in public, and isolating oneself at home if experiencing symptoms in order to limit transmission of the virus. Proper precautions, hygiene, and social behaviors are emphasized as the most important factors for staying healthy during the pandemic.
Imnci
The document provides information on Integrated Management of Newborn and Childhood Illness (IMNCI), a strategy developed by WHO and UNICEF to address the major causes of childhood mortality. It describes the main components of IMNCI, which include improved case management skills for health workers, improvements to health systems, and improvements in family/community practices. The clinical guidelines of IMNCI take a syndromic approach to assess, classify, identify treatment and counsel for common childhood illnesses like cough/pneumonia, diarrhea, fever, measles, ear problems, malnutrition and anemia. It provides treatment protocols for each illness based on severity of signs and symptoms. IMNCI aims to reduce deaths from preventable and treat
Integrated healt
The document summarizes key aspects of the Integrated Management of Childhood Illness (IMCI) strategy. IMCI relies on simple clinical signs to detect cases and empirical treatment classifications rather than exact diagnoses. It covers children aged 2 months to 5 years seen at first-level health facilities for common illnesses like cough, diarrhea, ear problems and fever. The IMCI process involves assessing the sick child for general danger signs, classifying illnesses, treating the child, counseling the mother, and providing follow-up care using standardized wall charts and job aids.
Flu 2010
This document provides an update on the 2010 flu season. It reviews the 2009 H1N1 pandemic, symptoms of the flu, why it can be life-threatening, flu vaccination recommendations, treatments, and prevention methods. It highlights that certain groups are at higher risk for flu complications, including the elderly, young children, pregnant women, and those with chronic health conditions. People exhibiting warning signs like difficulty breathing or persistent fever and cough should seek medical care.
ROJOSON-PEP-TALK: Home Management of COVID19 Patient (June 5, 2021)
This document provides guidance on home management of COVID-19 patients. It outlines how to identify and segregate household members who are suspected, probable or confirmed to have COVID-19. It describes monitoring symptoms and vital signs, providing supportive care, and stressing the importance of rest, nutrition, hydration and hygiene to build natural immunity. Advice is given on isolation periods and when a physician should be contacted by telemedicine. The objective is to empower patients to safely manage mild COVID-19 cases at home.
Coronavirus Disease 2019_Talk for GAD.pptx
The document provides information about COVID-19 and the ongoing pandemic. It discusses what COVID-19 is, how it spreads through droplets from talking, coughing or sneezing, and its common symptoms like fever and cough. It notes that while most cases are mild, some can be severe or fatal, especially in older people or those with underlying conditions. The document recommends prevention methods like frequent handwashing, social distancing, and wearing a face mask. It also outlines what to do if sick and recovering, including self-isolation. Contact tracing of those exposed is discussed as well to stop transmission.
What is coronavirus disease
The document provides information about COVID-19 including how it spreads, symptoms, diagnosis, treatment, and prevention. It is caused by the SARS-CoV-2 virus which is new and spreads between people. Common symptoms include fever, cough and shortness of breath. While most cases are mild, it can sometimes be severe or fatal. Prevention focuses on hand washing, social distancing and wearing masks. There is no specific treatment but symptoms can be treated and healthcare is needed for severe cases.
IMCI.pptx
This document provides guidelines for Integrated Management of Childhood Illnesses (IMCI). It describes how to assess, classify, and treat common childhood illnesses in children ages 2 months to 5 years. Key steps include checking for general danger signs requiring urgent referral, assessing main symptoms like cough, diarrhea, fever, ear problems, and malnutrition. Conditions are classified and specific treatments are recommended, including antibiotics, antimalarials, oral rehydration solution, zinc, and vitamin A. The document also provides guidance on immunizations, deworming medications, and teaching mothers how to provide treatment at home.
Acute respiratory infections
This document discusses acute respiratory infections (ARI), including their causes, transmission, clinical assessment, classification, treatment, and prevention. It describes the different bacterial and viral agents that can cause ARIs. Clinical assessment involves examining symptoms, breathing rate, chest indrawing, wheezing, and malnutrition. ARIs are classified based on severity and treated with antibiotics or symptomatic care. Prevention focuses on improved living conditions, nutrition, immunization including measles vaccine, Hib vaccine, and pneumococcal pneumonia vaccine.
acuterespiratoryinfections-161205075803.pdf
This document discusses acute respiratory infections (ARI), including their causes, transmission, clinical assessment, classification, treatment, and prevention. It notes that ARI can be classified as either upper or lower respiratory infections depending on the site of inflammation. Common bacterial and viral agents that cause ARI are described. Clinical assessment of ARI involves examining factors like breathing rate, chest indrawing, wheezing and malnutrition. Treatment depends on illness classification and may involve antibiotics, symptomatic relief or referral. Immunization and improved living conditions are emphasized for prevention.
Management of ari
Acute respiratory infections (ARIs), especially pneumonia, are a major cause of death among children under five globally. Pneumonia kills more children than any other illness. Improving case management through integrated management of childhood illnesses protocols and increasing access to quality care through community health workers can help reduce pneumonia mortality. Adopting strategies to improve nutrition, promote vaccination, reduce indoor air pollution, and prevent HIV can together reduce pneumonia burden substantially.
Covid 19 & and pregnancy
This document discusses COVID-19 and pregnancy. It outlines that COVID-19 infection does not seem to be worse for pregnant women or affect the fetus. Antenatal care is emphasized through telehealth to reduce risk of exposure. For suspected or confirmed COVID-19 in pregnancy, a multidisciplinary approach is recommended based on symptom severity and obstetric issues. Management includes isolation, testing, monitoring for maternal and fetal well-being, and individualizing care during labor and postpartum based on the mother's condition.
Brue ppt
This document describes the case of a 2-month-old male infant who presented with respiratory distress after being referred from another hospital. The child had experienced a seizure the previous day involving all four limbs and became unresponsive, requiring CPR and intubation. On admission, the child was irritable with inspiratory stridor and a fever. Initial workup showed laryngomalacia and bronchiolitis. During hospitalization, the child had two additional cardiac arrests and was treated with ventilation and antibiotics. Further workup including imaging, lumbar puncture, EEG and echocardiogram was negative. The child remained hospitalized for management and observation.
Abortion and Stillbirth
what is Abortion?
What is Stillbirth
what is the different between them?
How can we manage them?
IMNCI_ Introduction & Pneumonia
This power-point includes content on brief introduction and classification & management of pneumonia based on Integrated Management of Neonatal & Childhood Illness (IMNCI).
ROJOSON-PEP-TALK: Home Management of COVID19 Patient (May 22, 2021)
Home management of asymptomatic and mild COVID-19 patients involves family health management through isolation, preventing cross-infection, monitoring symptoms and vital signs daily under a physician's guidance via telemedicine, and maintaining innate immunity. The quarantine or isolation period typically ranges from 10 to 21 days until asymptomatic with improving symptoms for at least 3 days. COVID-19 testing is only recommended if results would change management.
Similar to Webinar: COVID-19 Updates with Stephanie Lambert (20)
ROJOSON-PEP-TALK: Home Management of COVID19 Patient (June 5, 2021)
ROJOSON-PEP-TALK: Home Management of COVID19 Patient (June 5, 2021)
ROJOSON-PEP-TALK: Home Management of COVID19 Patient (May 22, 2021)
ROJOSON-PEP-TALK: Home Management of COVID19 Patient (May 22, 2021)
More from TheChamber
Update ROE Chamber
This document introduces Lighthouse Recovery Community Center and its Recovery Oriented Employer Program. It summarizes that substance use disorders cost businesses thousands per year due to lost productivity. Lighthouse's program pairs employees in recovery with peer recovery coaches for confidential support to successfully manage their conditions. This increases recovery success rates from 11% with treatment alone to 50-60% when combining treatment, peer support, sober living and recovery-oriented employment. The program benefits employers through reduced costs and improved productivity, while benefiting employees through effective, confidential and sustainable support.
Manitowoc Industrial Athlete Presentation
The document discusses promoting sustainable wellness in the workplace. It provides an example schedule for Green Bay Packers running back AJ Dillon for January through February that includes employment, fitness routines, physical therapy, and recovery methods. It also lists personal benefits of wellness programs, lessons learned, and actions employers can take like communication strategies, assistance programs, onsite health services, and robust benefits.
Occupational Safety & Health Administration (OSHA) 2022 update
The document summarizes the 2022 update from the Occupational Safety & Health Administration (OSHA) Region 5. It outlines the top 10 OSHA violations so far in 2022, which include fall protection, hazard communication, and respiratory protection standards. It also discusses current national and local emphasis programs that OSHA is focused on, such as machine guarding, heat/cold stress, and construction suicide prevention. National programs center on hazards like combustible dust, coronavirus, and trenching/excavation safety. The presentation provides an overview of OSHA regulations and enforcement strategies to improve workplace safety.
NAMI PPT_Mental Wellness
This document discusses mental health, mental illness, and systemic solutions in the workplace. It defines mental health as a state of well-being that allows people to cope with stress and function well. Mental illness is a diagnosable disorder that impacts how one feels, thinks and acts. Common causes include genetics, trauma and stress. The document then outlines some ways companies are working to improve mental health through focusing on culture, benefits, policies, environment, outcomes measurements and innovation. It provides local resources for mental health support.
Sports Authority Presentation
Bellin Psychiatric Center is one of the largest mental health providers north of Milwaukee. It offers both inpatient and outpatient services, including inpatient hospital services for children/adolescents and adults, as well as inpatient adult detox services. Outpatient services include intensive outpatient programs for mental health and substance use, a DBT program, and outpatient psychiatric and therapy services. The center employs over 70 providers, including psychiatrists, nurse practitioners, psychologists, and therapists. Thirteen of its therapists provide school-based mental health services in 10 school districts and 21 school locations, with plans to expand to another district.
Wisconsin Economic Update
This document discusses Wisconsin's economic recovery and labor market challenges. It notes that while the economic recovery is underway, Wisconsin faces a labor quantity challenge as the workforce is not growing quickly enough. Technology will continue to advance and impact jobs through automation. The chief economist analyzes various factors influencing the labor supply and demand balance such as demographics, migration patterns, childcare access, wages, and automation. He discusses potential solutions like immigration, skills training, and increasing wages but notes fixing the workforce issue will require macro-level solutions.
Stroke Education for the Workplace
Stroke Education for the Workplace:
Why You Need It and What Employees Should Know
By
Rachel Reas MBA, BSN, RN
Neuroscience Market Manager, Aurora BayCare Medical Center
A Paradigm Shift: Work, COVID-19 & OSHA
A Paradigm Shift: Work, COVID-19 & OSHA
A 2021 OSHA Update - September 2021
Originally Done September 2020
By
Tom Fitzgerald, MSOB, PHR
OSHA Outreach Instructor 29 CFR 1910
Safety Advocate and Coach
Safety Fitz LLC
Psychological Safety
Psychological Safety: An Important Component for Safety in the Workplace
Psychological safety has been referred to as the single most important characteristic for successful teams and leads to decrease in turnover and increases in effectiveness. Psychological safety is the belief that your environment is safe for interpersonal risk-taking meaning that asking questions, pointing out problems, and suggesting innovation will be responded to in a respectful manner. This presentation will cover what psychological safety is, why it’s important, how to assess its presence, and tips on how to grow this in your workplace.
By
Paula Allen, MS, BSN, RN, CPPS and
Karen Allard, MS, BA, RN.
Patient Safety Specialists, Bellin Health
Stroke Education for the Workplace
This document provides information about strokes including key facts, risk factors, treatments, and prevention strategies. It notes that strokes are a leading cause of death and disability in the US, with about 795,000 occurring per year. Both ischemic and hemorrhagic strokes are medical emergencies requiring immediate treatment, with outcomes dependent on minimizing time to treatment. Common risk factors include hypertension, smoking, diabetes, high cholesterol, and atrial fibrillation. Signs of stroke include sudden numbness, confusion, trouble speaking, and vision changes. The document emphasizes the importance of recognizing signs early and calling 911 to receive rapid evaluation and treatment.
7 Tips to Fire Up Your Content for Nonprofit Marketing
The document provides 7 tips for non-profits to fire up their content marketing. Tip 1 is to plot objectives like engaging donors and telling stories. Tip 2 suggests considering a blog format for timely content and building relationships. Tip 3 is to repurpose content across different media. Tip 4 advises getting personal by sharing stories of real people and supporters. Tip 5 is to listen to the target audience. Tip 6 finds a balance of content types. Tip 7 is to get help from others to establish roles and capabilities. The tips aim to embrace new strategies and diversify content sources.
Chamber Free Low Cost Marketing Ideas
Enlightening session presented by a team of three seasoned marketing professionals with over 80 years of combined marketing experience to learn more about new and traditional free or low cost marketing techniques. You’ll go back to your workplace with a list of ideas for electronic, community focused and traditional marketing tips as well as other resources.
Customer Service in Manitowoc County: Bringing Fun To Life
The document discusses customer service best practices for businesses in Manitowoc County. It covers the importance of providing a welcoming greeting to customers, creating relationships with customers, and providing clear and timely information. It notes that 68% of customers do not return due to indifference or rudeness from staff. Additional topics covered include defusing angry customers, promoting local attractions, and using social media for customer service.
One page marketing plan
This one page marketing roadmap provides guidance on developing a marketing plan for a business. It outlines key elements to include such as describing the business, products/services, unique selling proposition, goals, target market, budget, marketing activities, and a calendar to plan activities over a 12 month period. The plan is intended to help business owners strategically grow their company through defining their offer, customers, and tactical marketing.
A Small Business Guide to a Marketing Plan
This 1-page marketing plan template provides guidance on developing an effective yet simple marketing plan. It includes sections for summarizing your business, products/services, goals, target market, budget, and marketing activities. The key aspects are to understand your customers and their needs, identify your unique selling proposition, and align your goals and tactics. Having a clear plan will help focus your efforts and guide your business forward.
Membership 101 presentation 2019
The document provides information about the Chamber of Manitowoc County, including its mission, staff, and services offered to member businesses. The Chamber aims to promote economic prosperity in the county through business referrals, marketing opportunities like advertising in its newsletter and savings card, and educational events and roundtables on topics like safety, leadership, and connecting with government. It outlines the various ways it helps member businesses promote themselves and connect with the local community.
The A,B,C,D/R" of Fall Protection
The final rule on walking-working surfaces from OSHA applies to general industry workplaces and covers horizontal and vertical surfaces like floors, stairs, roofs, ladders, ramps, and elevated walkways. It requires fall protection systems to meet new standards, including D-rings, snaphooks, and carabiners that can withstand 3,600 pounds of force without damage. Employers have additional time, ranging from 6 months to 5 years, to comply with requirements like certifying anchorages, adding fall protection to fixed ladders, and providing fall hazard training to workers. The rule became effective in January 2017 and aims to reduce injuries from falls in general industry.
Good morning, there is a person here that says they are an OSHA Compliance Sa...
This document provides guidance on preparing for and responding to an OSHA inspection. It advises relaxing as inspections are inevitable. It recommends being prepared by ensuring all required posters and documentation like training records and safety programs are up to date. It outlines how to conduct an opening meeting, tour, interviews and closing meeting professionally. It also discusses the citation process and available assistance after the inspection. The overall message is to see the inspection as a learning opportunity and make safety improvements.
Selling Safety
The document summarizes a safety symposium on selling safety initiatives in the workplace. It discusses calculating the direct and indirect costs of safety incidents, using process mapping and time studies to identify inefficiencies, and calculating return on investment for new safety equipment or processes. Tips are provided for building support for safety, creating pitches for new safety investments, and utilizing available resources to implement improvements. The goal is to demonstrate the financial benefits of safety programs to obtain support for initiatives.
So you want a team of Safety Champions?
This document outlines the responsibilities and goals of a Safety Champion program. It describes Safety Champions as a grassroots approach to injury prevention through personal engagement with safety issues. The responsibilities include conducting safety observations, coaching employees, promoting safety initiatives, and communicating safety trends. The goals are to encourage safety engagement, obtain universal safety support, and make safety the overriding priority to improve employee morale and involvement. A Safety Champion steering committee would provide support and tailor the program as needed.
More from TheChamber (20)
Occupational Safety & Health Administration (OSHA) 2022 update
Occupational Safety & Health Administration (OSHA) 2022 update
7 Tips to Fire Up Your Content for Nonprofit Marketing
7 Tips to Fire Up Your Content for Nonprofit Marketing
Customer Service in Manitowoc County: Bringing Fun To Life
Customer Service in Manitowoc County: Bringing Fun To Life
Good morning, there is a person here that says they are an OSHA Compliance Sa...
Good morning, there is a person here that says they are an OSHA Compliance Sa...
Recently uploaded
Top 10 Best Ayurvedic Kidney Stone Syrups in India
we have mentioned the best 10 ayurvedic Kidney Stone Syrups. You can check all these products and choose the best one for yourself.
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Top Effective Soaps for Fungal Skin Infections in India
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Learn about body grief and ways to cope with it. We will also explore methods to heal from this challenging experience.
The Best Ayurvedic Antacid Tablets in India
Treat the symptoms of indigestion, heartburn and stomach reflux with the 10 Best Ayurvedic Antacid Tablets in India.
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest VersionTop-Vitamin-Supplement-Brands-in-India List
Swisschem Dermacare provides the Top 10 Vitamin Supplement Brands in India. To know more about us give us call at our official number
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Do you have abnormal smell after periods? It may be vaginitis. Do not worry, herbal medicine Fuyan Pill can help you get a cure.
Journal Article Review on Rasamanikya
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
It includes regulation of combination products and medical devices. FDA and industry liaisons.
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Recently uploaded (20)
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Webinar: COVID-19 Updates with Stephanie Lambert
- 1. Manitowoc County COVID-19 Update October 13, 2021 Stephanie Lambert, MPH Health Officer
- 9. Placeholder – epi curve
- 13. High Risk Populations • Older adults • People with certain medical conditions • Pregnant people
- 14. High Risk Populations: Medical Conditions
- 15. High Risk Populations: Pregnant People Increased risk for Mom: • Admission to ICU • Ventilator • Death Increased risk for Baby: • Preterm Birth • Admission of baby to ICU
- 16. Long COVID • Some people report new or persistent symptoms weeks, months, or longer after infection • Anyone who had COVID-19 can get long-COVID • Reported after both symptomatic and asymptomatic infections
- 17. Long-COVID Symptoms • Difficulty breathing or shortness of breath • Tiredness or fatigue • Symptoms that get worse after physical or mental activities • Difficulty thinking or concentrating (“brain fog”) • Cough • Chest or stomach pain • Headache • Fast-beating or pounding heart • Joint or muscle pain • Pins-and-needles feeling • Diarrhea • Sleep problems • Fever • Dizziness on standing • Rash • Mood changes • Change in smell or taste • Changes in menstrual period cycles
- 18. Long COVID (continued) • Multi-Organ Effects of COVID-19 • Problems with many, if not all, body systems, including heart, lung, kidney, skin and brain functions • Autoimmune conditions
- 19. Care for those with Long-COVID • Post-COVID Care clinics • Prevea • Bellin • Long-COVID support groups • Disability rights
- 20. Place holder – vaccine data
- 21. -20 0 20 40 60 80 100 120 140 160 180 Acute Kidney Injury Arrhythmia Deep Vein Thrombosis Intracranial Hemorrhage Myocardial Infarction Myocarditis Pericarditis Pulmonary Embolism Adverse Events: COVID-19 Infection vs. Vaccination Risk difference per 100,000 persons who were vaccinated Risk difference per 100,000 persons infected with COVID-19 “BNT162b2 MRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.” New England Journal of Medicine, vol. 384, no. 20, 2021, pp. 1968–70. Crossref, doi:10.1056/nejmc2104281.
- 23. What Can You Do? (Individuals) • If you are not yet vaccinated – get your vaccine ASAP. • Wear a mask in all indoor public settings – regardless of vaccination status • Stay home if you are sick and seek testing if you have symptoms of COVID-19 • If you are a close contact of someone diagnosed with COVID-19 • And are VACCINATED: Wear a mask and monitor for symptoms for 14 days. Get tested 3-5 days following exposure • And are NOT vaccinated: Stay home and away from others (Quarantine) for 7- 14 days. Monitor for symptoms for 14 days.
- 24. If you test positive for COVID-19 • Isolate immediately (Stay home and away from others) • Notify close contacts • Stay in isolation until: • 10 days have passed since your positive test or symptom onset AND • You do not have a fever • Symptoms have improved without medication for at least 24 hours • If you are at high-risk for severe COVID-19 disease, speak to your doctor about accessing monoclonal antibody therapy • You do not need a negative test to be released from isolation
- 25. What Can You Do? (Employer) • Prioritize COVID-19 vaccination among staff • Require universal mask wearing among employees in indoor public settings • Promote physical distancing of at least 6 feet –including during breaks, meal-times, etc • Institute policies that encourage employees to stay home if sick and seek testing • Improve ventilation • Sanitize high touch surfaces
- 26. What’s next? • Boosters? • Youth vaccination? • Federal OSHA Guidelines
- 27. Thank you